Science and data for equitable gynecological cancer prevention: innovation and public health

Every year, millions of women around the world are diagnosed with gynecological cancer, a group of diseases that includes ovarian, cervical, endometrial, vulvar, and vaginal cancer, with ovarian cancer being the most lethal. Its impact is not limited to the clinical sphere: it affects entire families, the organization of health systems, and the way we understand prevention and care. Epidemiology, the discipline that studies how diseases are distributed and what factors influence them, becomes a fundamental tool for understanding the magnitude of this problem and guiding public health policies.

In the framework of World Gynecological Cancer Day, which is commemorated on September 20, we spoke with Maria Jose Sanchez, a physician, epidemiologist, and scientific director of the Granada Biosanitary Research Institute (ibs.GRANADA), director of the Granada Cancer Registry, professor, and head of consulting and research at the Andalusian School of Public Health (EASP), whose career is marked by cancer research and a commitment to public health care. Her approach combines science with a social perspective, addressing everything from prevention and early diagnosis to comprehensive patient care and equity in access to healthcare innovation.

Read the full interview with María José Sánchez, scientific director of ibs.GRANADA and professor at EASP at: Healthinking.